Case Report: Life-Threatening Fluoxetine-Linked Postoperative Bleeding Informed by Pharmacogenetic Evaluation

Sara Rogers, Patrick J. Silva, George Udeani, Monica Deleon, Sriarchala Mutyala, Ladan Panahi, Asim Abu-Baker, Gabriel Neal, Kenneth S. Ramos

Research output: Contribution to journalArticlepeer-review

Abstract

Background: Selective serotonin reuptake inhibitors (SSRI) are commonly used for the treatment of depression and anxiety. Inhibition of serotonin reuptake in platelets increases bleeding risk in patients taking SSRIs. Case: Here, we present the case of a 52-year-old patient who developed severe postsurgical bleeding requiring blood transfusion following panniculectomy. Conclusion: SSRI-induced bleeding is dose-related and strongly influenced by individual variations in drug metabolizing enzymes and transporters. Video abstract: BJYwPVEYn-uvqVov7uRYgK Supplementary file1 (MP4 8441 KB).

Original languageEnglish (US)
JournalDrugs in R and D
DOIs
StateAccepted/In press - 2024

ASJC Scopus subject areas

  • Pharmacology

Fingerprint

Dive into the research topics of 'Case Report: Life-Threatening Fluoxetine-Linked Postoperative Bleeding Informed by Pharmacogenetic Evaluation'. Together they form a unique fingerprint.

Cite this